These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19670296)

  • 1. Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats.
    Roy B; Bose A; Bhaumik U; Das A; Chatterjee N; Ghosh A; Darbar S; Sarkar AK; Sengupta P; Pal TK
    J Pharm Sci; 2010 Mar; 99(3):1535-47. PubMed ID: 19670296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin in rats.
    Chenel M; Barbot A; Dupuis A; Mimoz O; Paquereau J; Bouquet S; Couet W
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1952-7. PubMed ID: 12760873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.
    Dupuis A; Couet W; Paquereau J; Debarre S; Portron A; Jamois C; Bouquet S
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1682-7. PubMed ID: 11353611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemifloxacin for community-acquired pneumonia.
    Lode HM; Schmidt-Ionas M; Stahlmann R
    Expert Opin Investig Drugs; 2008 May; 17(5):779-86. PubMed ID: 18447602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis.
    Jivcu C; Gotfried M
    Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pharmacokinetic-pharmacodynamic target attainment of gemifloxacin against Streptococcus pneumoniae.
    Owens RC; Bhavnani SM; Ambrose PG
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):45-9. PubMed ID: 15629228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of gemifloxacin in different tissues of rat after oral dosing of gemifloxacin mesylate by LC-MS/MS and its application in drug tissue distribution study.
    Roy B; Das A; Bhaumik U; Sarkar AK; Bose A; Mukharjee J; Chakrabarty US; Das AK; Pal TK
    J Pharm Biomed Anal; 2010 Jun; 52(2):216-26. PubMed ID: 20092976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections.
    Blondeau JM; Tillotson G
    Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
    Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L; Manzor O; Pawlak J; Belian B
    Int J Antimicrob Agents; 2005 Jul; 26(1):81-4. PubMed ID: 15951159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A probable association of acute dystonia with gemifloxacin administration.
    Sharma DD; Aggarwal A; Sharma RC; Kumar R
    Indian J Med Sci; 2009 Dec; 63(12):557-60. PubMed ID: 20160381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK; Triller DM; Yong CS; Lodise TP
    Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.
    Islinger F; Bouw R; Stahl M; Lackner E; Zeleny P; Brunner M; Müller M; Eichler HG; Joukhadar C
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4246-9. PubMed ID: 15504848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats.
    Chenel M; Marchand S; Dupuis A; Lamarche I; Paquereau J; Pariat C; Couet W
    Br J Pharmacol; 2004 May; 142(2):323-30. PubMed ID: 15155539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolones in the management of community-acquired pneumonia in primary care.
    Wispelwey B; Schafer KR
    Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
    Ramji JV; Austin NE; Boyle GW; Chalker MH; Duncan G; Fairless AJ; Hollis FJ; McDonnell DF; Musick TJ; Shardlow PC
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
    Allen A; Vousden M; Lewis A
    Chemotherapy; 1999; 45(6):496-503. PubMed ID: 10567781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an efficient LC-microdialysis method for gemifloxacin quantitation in lung, kidney and liver of rats.
    de Araújo BV; Laureano JV; Grünspan LD; Dalla Costa T; Tasso L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():62-6. PubMed ID: 23411020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
    Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
    Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats.
    Visser SA; Smulders CJ; Reijers BP; Van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1158-67. PubMed ID: 12183676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.